Cardiol Therapeutics (CRDL) Share-based Compensation Growth (1y) (2021 - 2026)
Cardiol Therapeutics (CRDL) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 26.47% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 47.06% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.60% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 8.33% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | -69.71% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 40.00% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 59.27% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | -24.33% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 23.92% |
| 10 | Cardiol Therapeutics | 162.94 Mn | 142.76 Mn | - | 68.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.11% |
| Dec 31, 2025 | -4.07% |
| Sep 30, 2025 | -46.78% |
| Jun 30, 2025 | 23.61% |
| Mar 31, 2025 | 19.40% |
| Dec 31, 2024 | 202.86% |
| Sep 30, 2024 | 274.45% |
| Jun 30, 2024 | 207.71% |
| Mar 31, 2024 | 112.04% |
| Dec 31, 2023 | 6.52% |
| Sep 30, 2023 | 4.15% |
| Jun 30, 2023 | 180.02% |
| Mar 31, 2023 | -62.50% |
| Dec 31, 2022 | -80.82% |
| Sep 30, 2022 | 87.31% |
| Jun 30, 2022 | -178.56% |
| Mar 31, 2022 | -50.24% |
| Dec 31, 2021 | 1,356.27% |
| Sep 30, 2021 | 60.62% |
| Jun 30, 2021 | -12.87% |